1-8 of 8
Roberto Bellucci, PhD
Close
Sort by
Journal Articles

JAK1 and JAK2 Modulate Tumor Cell Susceptibility To Natural Killer (NK) Cells Through Regulation Of PDL1 Expression

Roberto Bellucci, PhD, Allison Martin, BS, Davide Bommarito, Kathy S. Wang, PhD, Gordon J Freeman, PhD, Jerome Ritz, MD
Journal: Blood
Blood (2013) 122 (21): 3472.
https://doi.org/10.1182/blood.V122.21.3472.3472
Published: 2013
Journal Articles

Enhancement of Tumor Cell Susceptibility to NK Cell Activity Through Inhibition of the PI3K Signaling Pathway.

Davide Bommarito, Allison Martin, BS, Maria-Dorothea Nastke, Jerome Ritz, MD, Roberto Bellucci, PhD
Journal: Blood
Blood (2012) 120 (21): 2152.
https://doi.org/10.1182/blood.V120.21.2152.2152
Published: 2012
Journal Articles

Targeting the Interferon-γ (IFN-γ) Pathway to Enhance Susceptibility of Multiple Myeloma Tumor Cells to NK Cell Lysis

Roberto Bellucci, PhD, Allison Martin, BS, Davide Bommarito, Jerome Ritz, MD
Journal: Blood
Blood (2012) 120 (21): 4013.
https://doi.org/10.1182/blood.V120.21.4013.4013
Published: 2012
Journal Articles

JAK1 and JAK2 Modulate Myeloma Cell Susceptibility to NK Cells Through the Interferon Gamma (IFN-γ) Pathway,

Roberto Bellucci, PhD, Allison Martin, BS, Marc Buren, Hong-Nam Nguyen, BS, Davide Bommarito, Jerome Ritz, MD
Journal: Blood
Blood (2011) 118 (21): 3960.
https://doi.org/10.1182/blood.V118.21.3960.3960
Published: 2011
Journal Articles

Identification of Novel Antigens with Induced Immune Response in MGUS.

Simona Blotta, MD, Hiroshi Yasui, MD, Pierfrancesco Tassone, MD, Roberto Bellucci, PhD, Yu-Tzu Tai, PhD, Rao Prabhala, PhD, Masood A. Shammas, PhD, Pierosandro Tagliaferri, MD, Klaus Podar, MD, PhD, Paola E. Neri, MD, Mariateresa Fulciniti, PhD, Vidit Munshi, Dharminder Chauhan, PhD, Teru Hideshima, MD, PhD, Salvatore Venuta, MD, PhD, Jerome Ritz, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD
Journal: Blood
Blood (2006) 108 (11): 655.
https://doi.org/10.1182/blood.V108.11.655.655
Published: 2006
Journal Articles

Patients Who Respond to Donor Lymphocyte Infusion (DLI) Have an Antibody Response Against PDC-E2, the Immunodominant Autoantigens of Primary Biliary Cirrhosis (PBC), but with Different Specificity.

Roberto Bellucci, PhD, Meagan Gallagher, Sabine Oertelt, MD, Emmanuel Zorn, PhD, Edwin P. Alyea, MD, Robert J. Soiffer, MD, Catherine J. Wu, MD, Nikhil C. Munshi, MD, Eric Gershwin, MD, Jerome Ritz, MD
Journal: Blood
Blood (2005) 106 (11): 3105.
https://doi.org/10.1182/blood.V106.11.3105.3105
Published: 2005
Journal Articles

Identification of Target Antigens Recognized in MGUS for Immunotherapeutic Approaches.

Simona Blotta, MD, Roberto Bellucci, PhD, Pierfrancesco Tassone, MD, Rao Prabhala, PhD, Paola Neri, MD, Masood Shammas, PhD, Ramesh R. Batchu, PhD, Jooeun E. Bae, PhD, Cheng Li, PhD, Salvatore Venuta, MD, Jerome Ritz, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD
Journal: Blood
Blood (2005) 106 (11): 3463.
https://doi.org/10.1182/blood.V106.11.3463.3463
Published: 2005
Journal Articles

IL-2 Therapy Promotes the Expansion of Human CD4+CD25+ Regulatory T Cells and Selectively Upregulates the Expression of FOXP3 in T Cells In Vivo.

Emmanuel Zorn, PhD, Erik A. Nelson, PhD, Mehrdad Mohseni, MD, Despina Litsa, BSc, Haesook Kim, PhD, Roberto Bellucci, PhD, Fabrice Porcheray, PharmD, Christine Canning, MD, Robert J. Soiffer, MD, Jerome Ritz, MD
Journal: Blood
Blood (2005) 106 (11): 1257.
https://doi.org/10.1182/blood.V106.11.1257.1257
Published: 2005